Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

MIP Technologies Presents New Range of RENSA™ Industrial Resins

Published: Monday, January 27, 2014
Last Updated: Monday, January 27, 2014
Bookmark and Share
New range of polymeric separation resins for industrial use.

MIP Technologies has presented a new range of RENSA™ industrial resins. The company is now offering industrial resin products together with recently published product- and application notes on the website http://www.biotage.com/product-page/rensa-bulk-resins.

These notes describe the materials and physical properties as well as the performance of the new resins so that customers can select the appropriate resin for their specific separation requirements.

“The food, beverage, pharma, consumer products and life science industries are constantly confronted with new separation challenges as the result of an ever changing regulatory environment and the pressure to achieve a better process economy. In response to this need, MIP Technologies has established a broad range of polymeric materials spanning a wide chemistry landscape that will enable these industries to overcome those separation challenges” says Dr. Ecevit Yilmaz, Product Manager – Industrial Resins.

Dr. Yilmaz continued, “The separation materials can be used by our customers at the pilot and production scale to either extract undesired impurities or to enrich specific target compounds from complex matrices.”

“The area of Industrial Scale applications is an important new pillar in the business of Biotage. We will continue to invest into the development of our Industrial Resin portfolio and we will further expand the range of engineered polymeric adsorbents. This will allow us to offer unique and highly selective separation solutions to our wide range of industrial customers” says Dr. Ecevit Yilmaz.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Making It Personal
Cancer vaccine linked to increased immune response against leukemia cells.
Improved Stability, Shelf Life of Protein Drugs
Study improves protein drug stability and extend their shelf life by tested a novel route for non-covalent protein modification.
More Effective Strategy for Producing Flu Vaccines
Researchers have developed a virus backbone, allowing producers to grow vaccine viruses in mammalian cells, rather than in eggs.
Improving Drug Production with Computer Model
A model has been developed that can be used to improve and accelerate the production of biotherapeutics, cancer drugs, and vaccines.
First New HIV Vaccine Study for Seven Years Begins
South Africa hosts historic clinical trial of experimental HIV vaccine aiming to safely prevent HIV infection.
Vaccination Against UTIs
Researchers have successfully vaccinated mice against E.coli growth in the bladder and kidneys.
First Steps to Neutralising Zika
Researchers have discovered a highly potent antibody that neutralises Zika infection at a cellular level.
Human Astrovirus Structure Could Lead to Therapies, Vaccines
Study shows where neutralizing antibody binds to human astrovirus, a leading cause of viral diarrhoea in children, elderly, and the immune-compromised.
Fighting Off HIV Infection Closer to Reality
Researchers have made significant progress in the development of a potential vaccine to protect against HIV infection.
Powerful New Tools to Combat Zika
Researchers have created a way to replicate the stucture of Zika virus, removing the genes that make the virus infectious.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!